← Back to Search

Behavioural Intervention

Cranial nerve non-invasive neuromodulation (CN-NINM) for Stroke

N/A
Waitlist Available
Led By Marie-Hélène Milot, Ph.D.
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up information will be assessed through study completion, an average of 9 months
Awards & highlights

Summary

This trial is investigating whether a new brain stimulation technique can help improve motor function and reduce pain in people who have had a stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~information will be assessed through study completion, an average of 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and information will be assessed through study completion, an average of 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to the intervention (training program and CN-NINM) in percent
Dropped out rate of the project in percent and the reasons
Number of participants with CN-NINM-related adverse events as assessed by a questionnaire
+2 more
Secondary outcome measures
Change in UL functional performance on the Wolf Motor Function Test
Change in UL motor function on the Fugl-Meyer Stroke Assessment Scale
Change in affected grip strength on the JAMAR dynamometer
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: strength training interventionExperimental Treatment1 Intervention
Strength training of the affected upper limb in chronic stroke survivors
Group II: Cranial nerve non-invasive neuromodulation (CN-NINM)Experimental Treatment1 Intervention
CN-NINM will be applied during each session of the strength training intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Strength training intervention
2022
N/A
~20
Cranial nerve non-invasive neuromodulation (CN-NINM)
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
300 Previous Clinical Trials
69,941 Total Patients Enrolled
9 Trials studying Stroke
1,170 Patients Enrolled for Stroke
Marie-Hélène Milot, Ph.D.Principal InvestigatorUniversité de Sherbrooke
Guillaume Léonard, Ph.D.Principal InvestigatorUniversité de Sherbrooke
~4 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top